Drug makers and drug regulators: too close for comfort. A study of the Canadian situation
PulseAugur coverage of Drug makers and drug regulators: too close for comfort. A study of the Canadian situation — every cluster mentioning Drug makers and drug regulators: too close for comfort. A study of the Canadian situation across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Singapore attracts top drug makers but needs commercial wins
Singapore has attracted eight of the top ten global drug makers, aiming to be Southeast Asia's leading biomedicine hub. Despite significant investment and initiatives, the city-state faces challenges in translating scie…
-
Drug makers eye market withdrawal over MFN and IRA pricing policies
Drug manufacturers are expressing concerns regarding the Most-Favored-Nation (MFN) and Inflation Reduction Act (IRA) pricing policies. A key worry is that these policies might lead companies to withdraw existing drugs f…